Triad Isotopes Announces Investment by Parthenon Capital.ORLANDO, Fla. -- Triad Isotopes Inc. announced today the acquisition and merger of three leading nuclear pharmacy Nuclear Pharmacy involves the preparation of radioactive materials that will be used to diagnose and treat specific diseases. It was the first pharmacy specialty established in 1978 by the Board of Pharmaceutical Specialties. operators, Diversified Pharmacy Group, Cox Nuclear Pharmacies and Coastal Nuclear Pharmacies. Triad was funded by Parthenon Capital, a leading middle market private equity fund with offices in San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden and Boston. As a combined business, Triad now constitutes one of the largest independent nuclear pharmacy companies in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Triad was formed in partnership with Dom Meffe who will become CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of the company. The founders of each of the merged companies, Steve Putnal, William Cox People named William Cox include:
Dom Meffe, CEO of Triad stated, "We are very excited to build this business in partnership with Parthenon Capital." He added, "Triad will combine the strengths and knowledge of independent operators with the capital and resources of a larger company to provide superior solutions to the customer." Casey Lynch, the senior member of Parthenon's team who led the 15-month process of simultaneously merging the three companies, said, "After having evaluated the pharmacy space for more than a year previously, we are thrilled to be partnering with Dom Meffe in such a dynamic market." He added, "Nuclear pharmacies provide a critical service to a large and growing segment of healthcare providers. Triad is well positioned to grow through both increases in diagnostic and therapeutic procedures as well as through selected acquisitions. Once again, we were able to leverage the deep resources of the Parthenon team and a long term commitment to building industry expertise to pull off a highly complex transaction." About Triad Isotopes Inc. Triad compounds and distributes radiopharmaceuticals that are used for both diagnostic imaging procedures as well as for treatment of certain diseases. The company has 20 locations located throughout the southeastern United States and will be headquartered in Orlando, Florida The city of Orlando is a major city in central Florida and is the county seat of Orange County, Florida. According to the 2000 census, the city population was 185,951. A 2006 U.S. . About Parthenon Capital Parthenon Capital is a private equity firm with over $1.5 billion of capital under management and offices in Boston and San Francisco. The firm provides capital and strategic resources to growing middle market companies for acquisitions, internal growth strategies and shareholder liquidity. Parthenon provides equity to companies with revenues between $50 million - $500 million. The firm invests in a wide variety of industries with a particular expertise in Business and Financial Services The examples and perspective in this article or section may not represent a worldwide view of the subject. Please [ improve this article] or discuss the issue on the talk page. , Healthcare, Distribution/Logistics, and IP-Driven Manufacturing, Products and Services. For more information, visit www.parthenoncapital.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion